Single Ascending Dose Safety and Pharmacokinetics of CDRI-97/78: First-in-Human Study of a Novel Antimalarial Drug
Figure 2
Volunteer screening flowchart: for ascending dose study, 50 normal healthy human volunteers were screened from 63 volunteers, while for single dose pharmacokinetics study 16 healthy volunteers were from 20 volunteers.
